1251 related articles for article (PubMed ID: 34071457)
1. Physical Exercise-Induced Myokines in Neurodegenerative Diseases.
Lee B; Shin M; Park Y; Won SY; Cho KS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071457
[TBL] [Abstract][Full Text] [Related]
2. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
Mattson MP
Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
[TBL] [Abstract][Full Text] [Related]
3. Targeting stress granules in neurodegenerative diseases: A focus on biological function and dynamics disorders.
Fang M; Liu Y; Huang C; Fan S
Biofactors; 2024; 50(3):422-438. PubMed ID: 37966813
[TBL] [Abstract][Full Text] [Related]
4. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
5. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
Olesen MA; Villavicencio-Tejo F; Quintanilla RA
Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Neuromolecular Med; 2018 Jun; 20(2):174-204. PubMed ID: 29572723
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
Weng YT; Chang YM; Chern Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system.
Petrucelli L; Dawson TM
Ann Med; 2004; 36(4):315-20. PubMed ID: 15224658
[TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative disorders and gut-brain interactions.
Singh A; Dawson TM; Kulkarni S
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196307
[TBL] [Abstract][Full Text] [Related]
10. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.
Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA
Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.
Tanaka M; Toldi J; Vécsei L
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244523
[TBL] [Abstract][Full Text] [Related]
12. Histone Methylation Regulation in Neurodegenerative Disorders.
Basavarajappa BS; Subbanna S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
[TBL] [Abstract][Full Text] [Related]
13. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
Chen D; Zhang T; Lee TH
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
[TBL] [Abstract][Full Text] [Related]
14. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
15. The Microbiome as a Modifier of Neurodegenerative Disease Risk.
Fang P; Kazmi SA; Jameson KG; Hsiao EY
Cell Host Microbe; 2020 Aug; 28(2):201-222. PubMed ID: 32791113
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
Mariani E; Polidori MC; Cherubini A; Mecocci P
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
[TBL] [Abstract][Full Text] [Related]
17. Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review.
Dailah HG
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364033
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications.
Giri PM; Banerjee A; Ghosal A; Layek B
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612804
[TBL] [Abstract][Full Text] [Related]
19. Role of connexins in neurodegenerative diseases (Review).
Xing J; Xu C
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
